Selected research
Market Structure
Global Hospital and Nursing Home Probiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Hospital and Nursing Home Probiotics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Hospital and Nursing Home Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Hospital and Nursing Home Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hospital and Nursing Home Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Hospital and Nursing Home Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Hospital and Nursing Home Probiotics include American Lifeline, Becton Dickinson and Company, Bio - K Plus International, Eva Nutra, Mercola, Nebraska Cultures, Nutraceutix, NutraScience Labs and Probium, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Hospital and Nursing Home Probiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hospital and Nursing Home Probiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hospital and Nursing Home Probiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hospital and Nursing Home Probiotics market size, projected growth trends, production technologies, key applications, and end-use industries.
Hospital and Nursing Home Probiotics Segment by Company
American Lifeline
Becton Dickinson and Company
Bio - K Plus International
Eva Nutra
Mercola
Nebraska Cultures
Nutraceutix
NutraScience Labs
Probium
Protexin
Rising Pharmaceuticals
UP4 Probiotics
Vitakem Nutraceuticals
Hospital and Nursing Home Probiotics Segment by Type
Gram-positive Cocci
Lactobacillus
Bifidobacterium
Others
Hospital and Nursing Home Probiotics Segment by Application
Immunity
Wellness
Gut Health
Others
Hospital and Nursing Home Probiotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital and Nursing Home Probiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hospital and Nursing Home Probiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital and Nursing Home Probiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Hospital and Nursing Home Probiotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital and Nursing Home Probiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hospital and Nursing Home Probiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Hospital and Nursing Home Probiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Gram-positive Cocci
- Lactobacillus
- Bifidobacterium
- Others
Applications
- Immunity
- Wellness
- Gut Health
- Others
Companies covered
- American Lifeline
- Becton Dickinson and Company
- Bio - K Plus International
- Eva Nutra
- Mercola
- Nebraska Cultures
- Nutraceutix
- NutraScience Labs
- Probium
- Protexin
- Rising Pharmaceuticals
- UP4 Probiotics
- Vitakem Nutraceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Hospital and Nursing Home Probiotics Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Hospital and Nursing Home Probiotics Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Hospital and Nursing Home Probiotics Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Hospital and Nursing Home Probiotics Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Hospital and Nursing Home Probiotics Market Dynamics
- 2.1 Hospital and Nursing Home Probiotics Industry Trends
- 2.2 Hospital and Nursing Home Probiotics Industry Drivers
- 2.3 Hospital and Nursing Home Probiotics Industry Opportunities and Challenges
- 2.4 Hospital and Nursing Home Probiotics Industry Restraints
3 Hospital and Nursing Home Probiotics Market by Manufacturers
- 3.1 Global Hospital and Nursing Home Probiotics Revenue by Manufacturers (2021-2026)
- 3.2 Global Hospital and Nursing Home Probiotics Sales by Manufacturers (2021-2026)
- 3.3 Global Hospital and Nursing Home Probiotics Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Hospital and Nursing Home Probiotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hospital and Nursing Home Probiotics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Hospital and Nursing Home Probiotics Manufacturers, Product Type & Application
- 3.7 Global Hospital and Nursing Home Probiotics Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hospital and Nursing Home Probiotics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hospital and Nursing Home Probiotics Players Market Share by Revenue in 2025
- 3.8.3 2025 Hospital and Nursing Home Probiotics Tier 1, Tier 2, and Tier 3
4 Hospital and Nursing Home Probiotics Market by Type
- 4.1 Hospital and Nursing Home Probiotics Type Introduction
- 4.1.1 Gram-positive Cocci
- 4.1.2 Lactobacillus
- 4.1.3 Bifidobacterium
- 4.1.4 Others
- 4.2 Global Hospital and Nursing Home Probiotics Sales by Type
- 4.2.1 Global Hospital and Nursing Home Probiotics Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Hospital and Nursing Home Probiotics Sales by Type (2021-2032)
- 4.2.3 Global Hospital and Nursing Home Probiotics Sales Market Share by Type (2021-2032)
- 4.3 Global Hospital and Nursing Home Probiotics Revenue by Type
- 4.3.1 Global Hospital and Nursing Home Probiotics Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Hospital and Nursing Home Probiotics Revenue by Type (2021-2032)
- 4.3.3 Global Hospital and Nursing Home Probiotics Revenue Market Share by Type (2021-2032)
5 Hospital and Nursing Home Probiotics Market by Application
- 5.1 Hospital and Nursing Home Probiotics Application Introduction
- 5.1.1 Immunity
- 5.1.2 Wellness
- 5.1.3 Gut Health
- 5.1.4 Others
- 5.2 Global Hospital and Nursing Home Probiotics Sales by Application
- 5.2.1 Global Hospital and Nursing Home Probiotics Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Hospital and Nursing Home Probiotics Sales by Application (2021-2032)
- 5.2.3 Global Hospital and Nursing Home Probiotics Sales Market Share by Application (2021-2032)
- 5.3 Global Hospital and Nursing Home Probiotics Revenue by Application
- 5.3.1 Global Hospital and Nursing Home Probiotics Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Hospital and Nursing Home Probiotics Revenue by Application (2021-2032)
- 5.3.3 Global Hospital and Nursing Home Probiotics Revenue Market Share by Application (2021-2032)
6 Global Hospital and Nursing Home Probiotics Sales by Region
- 6.1 Global Hospital and Nursing Home Probiotics Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Hospital and Nursing Home Probiotics Sales by Region (2021-2032)
- 6.2.1 Global Hospital and Nursing Home Probiotics Sales by Region (2021-2026)
- 6.2.2 Global Hospital and Nursing Home Probiotics Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Hospital and Nursing Home Probiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Hospital and Nursing Home Probiotics Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Hospital and Nursing Home Probiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Hospital and Nursing Home Probiotics Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Hospital and Nursing Home Probiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Hospital and Nursing Home Probiotics Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Hospital and Nursing Home Probiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Hospital and Nursing Home Probiotics Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Hospital and Nursing Home Probiotics Revenue by Region
- 7.1 Global Hospital and Nursing Home Probiotics Revenue by Region
- 7.1.1 Global Hospital and Nursing Home Probiotics Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Hospital and Nursing Home Probiotics Revenue by Region (2021-2026)
- 7.1.3 Global Hospital and Nursing Home Probiotics Revenue by Region (2027-2032)
- 7.1.4 Global Hospital and Nursing Home Probiotics Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Hospital and Nursing Home Probiotics Revenue (2021-2032)
- 7.2.2 North America Hospital and Nursing Home Probiotics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Hospital and Nursing Home Probiotics Revenue (2021-2032)
- 7.3.2 Europe Hospital and Nursing Home Probiotics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Hospital and Nursing Home Probiotics Revenue (2021-2032)
- 7.4.2 Asia-Pacific Hospital and Nursing Home Probiotics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Hospital and Nursing Home Probiotics Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Hospital and Nursing Home Probiotics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 American Lifeline
- 8.1.1 American Lifeline Company Information
- 8.1.2 American Lifeline Business Overview
- 8.1.3 American Lifeline Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 American Lifeline Hospital and Nursing Home Probiotics Product Portfolio
- 8.1.5 American Lifeline Recent Developments
- 8.2 Becton Dickinson and Company
- 8.2.1 Becton Dickinson and Company Company Information
- 8.2.2 Becton Dickinson and Company Business Overview
- 8.2.3 Becton Dickinson and Company Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Becton Dickinson and Company Hospital and Nursing Home Probiotics Product Portfolio
- 8.2.5 Becton Dickinson and Company Recent Developments
- 8.3 Bio - K Plus International
- 8.3.1 Bio - K Plus International Company Information
- 8.3.2 Bio - K Plus International Business Overview
- 8.3.3 Bio - K Plus International Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bio - K Plus International Hospital and Nursing Home Probiotics Product Portfolio
- 8.3.5 Bio - K Plus International Recent Developments
- 8.4 Eva Nutra
- 8.4.1 Eva Nutra Company Information
- 8.4.2 Eva Nutra Business Overview
- 8.4.3 Eva Nutra Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Eva Nutra Hospital and Nursing Home Probiotics Product Portfolio
- 8.4.5 Eva Nutra Recent Developments
- 8.5 Mercola
- 8.5.1 Mercola Company Information
- 8.5.2 Mercola Business Overview
- 8.5.3 Mercola Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Mercola Hospital and Nursing Home Probiotics Product Portfolio
- 8.5.5 Mercola Recent Developments
- 8.6 Nebraska Cultures
- 8.6.1 Nebraska Cultures Company Information
- 8.6.2 Nebraska Cultures Business Overview
- 8.6.3 Nebraska Cultures Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Nebraska Cultures Hospital and Nursing Home Probiotics Product Portfolio
- 8.6.5 Nebraska Cultures Recent Developments
- 8.7 Nutraceutix
- 8.7.1 Nutraceutix Company Information
- 8.7.2 Nutraceutix Business Overview
- 8.7.3 Nutraceutix Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Nutraceutix Hospital and Nursing Home Probiotics Product Portfolio
- 8.7.5 Nutraceutix Recent Developments
- 8.8 NutraScience Labs
- 8.8.1 NutraScience Labs Company Information
- 8.8.2 NutraScience Labs Business Overview
- 8.8.3 NutraScience Labs Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 NutraScience Labs Hospital and Nursing Home Probiotics Product Portfolio
- 8.8.5 NutraScience Labs Recent Developments
- 8.9 Probium
- 8.9.1 Probium Company Information
- 8.9.2 Probium Business Overview
- 8.9.3 Probium Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Probium Hospital and Nursing Home Probiotics Product Portfolio
- 8.9.5 Probium Recent Developments
- 8.10 Protexin
- 8.10.1 Protexin Company Information
- 8.10.2 Protexin Business Overview
- 8.10.3 Protexin Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Protexin Hospital and Nursing Home Probiotics Product Portfolio
- 8.10.5 Protexin Recent Developments
- 8.11 Rising Pharmaceuticals
- 8.11.1 Rising Pharmaceuticals Company Information
- 8.11.2 Rising Pharmaceuticals Business Overview
- 8.11.3 Rising Pharmaceuticals Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Rising Pharmaceuticals Hospital and Nursing Home Probiotics Product Portfolio
- 8.11.5 Rising Pharmaceuticals Recent Developments
- 8.12 UP4 Probiotics
- 8.12.1 UP4 Probiotics Company Information
- 8.12.2 UP4 Probiotics Business Overview
- 8.12.3 UP4 Probiotics Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 UP4 Probiotics Hospital and Nursing Home Probiotics Product Portfolio
- 8.12.5 UP4 Probiotics Recent Developments
- 8.13 Vitakem Nutraceuticals
- 8.13.1 Vitakem Nutraceuticals Company Information
- 8.13.2 Vitakem Nutraceuticals Business Overview
- 8.13.3 Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Product Portfolio
- 8.13.5 Vitakem Nutraceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Hospital and Nursing Home Probiotics Value Chain Analysis
- 9.1.1 Hospital and Nursing Home Probiotics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Hospital and Nursing Home Probiotics Production Mode & Process
- 9.2 Hospital and Nursing Home Probiotics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hospital and Nursing Home Probiotics Distributors
- 9.2.3 Hospital and Nursing Home Probiotics Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst